Dr. Stephen Friend will deliver the 2014 Wilder Penfield Lecture entitled “Exploring multidimensional clinical space” at 4:00 pm on November 28, 2014 at the Montreal Neurological Institute and Hospital (The Neuro), McGill University. A reception will follow. Dr. Friend is the President, of Sage Bionetworks in Seattle, USA.
The Penfield Lecture was inaugurated in 1985 to honour Wilder Penfield, pioneering neurosurgeon and founder of the MNI.
For more information and to register: www.neuroevents.mcgill.ca
Sir Marc Feldmann, 2014 Canada Gairdner International Laureate, Head of the Kennedy Institute of Rheumatology, University of Oxford, Headington, Oxford, UK, will deliver his lecture, ANTI-TNF THERAPY: Discovery, present status and what might the future hold? as part of the 2014 Gairdner National Program. Sir Marc Feldmann is being recognized "For the discovery of anti-TNF therapy for the treatment of rheumatoid arthritis and other inflammatory diseases".
Dr. Alan Evans, a pioneering scientist who has helped map the human brain, has been awarded the Margolese National Brain Disorders Prize by the University of British Columbia. Dr. Evans is a researcher at the Montreal Neurological Institute and the James McGill Professor of Neurology and Neurosurgery, Psychiatry and Biomedical Engineering at McGill University.
McGill University is mourning the passing of Rosalind Goodman, a devoted alumna, generous philanthropist, and tireless volunteer, who committed herself to energizing cancer research activities at McGill and to educating others about the disease. It is an illness she fought and survived in 2007, but one that ultimately took her life on Monday, Aug. 11.
With this issue of the spotlight, we would like to congratulate Dr. Brett Thombs who is the recipient of the 2014 Principal’s Prize for Outstanding Emergent Researchers. This award was created in 2013 to encourage and celebrate McGill’s most outstanding earl-career researchers, as well as to provide them with an advantage as they apply for external awards by adding a prestigious internal distinction to their list of accomplishments.
Click to view: Department of Psychiatry Newsletter - Summer 2014
Please join us in congratulating the recipients of the CIHR operating grants competition.
Scientists at the Montreal Neurological Institute and Hospital, McGill University and McGill University Health Centre have shown that a member of the protein family known as SUMO (small ubiquitin-like modifier) is a key to why tumour cells multiply uncontrollably, especially in the case of glioblastoma. The SUMO family proteins modify other proteins and the SUMOylation of proteins are critical for many cellular processes.
The Quartier de l’innovation de Montréal (QI) is proud to announce the appointment of Damien Silès as Executive Director. Mr. Silès, who is currently serving as General Manager of the Société de développement social de Ville-Marie, will take up his duties with the QI on July 16, 2014.